Anti-Cancer Agents and Biological Therapy
Oncological Emergencies
Clinical Pharmacology of Anti-Cancer Agents
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
Perioperative Pembrolizumab Strategy Improves Resectable NSCLC Outcomes
Third-Line Trifluridine–Tipiracil Plus Bevacizumab ‘Represents New Standard Of Care’ For mCRC
Zolbetuximab Demonstrates Survival Gain For Advanced Gastric, Gastro-oesophageal Junction Cancer
TRIANGLE Points To Ibrutinib Benefits For Younger Mantle Cell Lymphoma Patients
Early Trials Confirm KRAS G12C-Mutated Colorectal Cancer Is ‘Druggable’
E-Learning
ESMO E-Learning: PARP Inhibitors: Past, Present and Future
ESMO E-Learning: Cardiotoxicity in Oncology Practice
ESMO E-Learning: Multimodular Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
ESMO V-Learning: BRCA Across Tumour Types
ESMO E-Learning: Management of Cancer Associated Thrombosis
Meeting resources
Management of Treatment-related Side Effects
Presenter: M. Ducreux, FR
Session: Session 5 - Metastatic Colorectal Cancer: Maintenance and Further Lines
Resources:
Slides
Webcast
Participants Clinical Case Discussion - Surgery and Triplet Chemotherapy with Liver-only Metastatic Disease
Presenter: G. Adžić, HR
Session: Session 4 - Metastatic Colorectal Cancer: Special Clinical Situations
Resources:
Slides
Webcast
Neoadjuvant Chemotherapy for Localised Colon Cancer as a Potential Option
Presenter: J. Seligmann, UK
Session: Session 1 - Localised Colon Cancer – Part 1
Resources:
Slides
Webcast
Case 1: Detection of treatment toxicity through remote monitoring
Presenter: Martina Pagliuca
Session: YO Clinical case discussion
Resources:
Slides
Webcast
Current ADC landscape
Presenter: Veronique Dieras
Session: HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers
Resources:
Slides
Webcast